US Warns China Against Helping Russia. What?!

via RT


Washington has “an array of tools” to deal with foreign companies that refuse to observe US sanctions

Ned Price, a spokesperson for US President Joe Biden’s State Department, threatened Chinese businesses with economic punishment if they decide to work with Russia through any hypothetical US sanctions.

During a press conference on Thursday, Price claimed the US has “an array of tools that we can deploy if we see foreign companies, including those in China, doing their best to backfill US export control actions, to evade them, to get around them.”

“If Russia thinks that it will be in a position… to mitigate some of those consequences, by a closer relationship with [China], that is not the case. It will actually make the Russian economy, in many ways, more brittle,” Price warned, in reference to hypothetical US sanctions against Moscow over a hypothetical Russian invasion of Ukraine.

Price continued to warn Russia it cannot survive without the West, claiming that “if you deny yourself the ability to transact with the West, to import with the West, from Europe, from the United States, you are going to significantly degrade your productive capacity and your innovative potential.”

In the same press conference, Price claimed to have US intelligence evidence that Russia was planning a false flag attack in Ukraine to justify an invasion of the country. Price was berated, however, by an AP journalist for refusing to provide a single piece of evidence to the public to justify such claims.

Moscow has repeatedly dismissed accusations that it’s planning an invasion of Ukraine as “hysteria”, and even Kiev at one point has criticized Western officials and media for damaging its economy with constant fear mongering about an “imminent” war.

Corona Investigative Committee Announces Grand Jury Trial

A Grand Jury Trial against Covid crimes starts on 5 February 2022, the Corona Investigative Committee announced on Monday.

“In serious criminal cases in the U.S., a so-called grand jury is presented with the evidence at hand to convince them that this evidence is sufficient to bring public charges against the defendants.

“We are adopting this model to prove to the public, with the help of real witnesses, lawyers, a judge and experts from around the world, that we are dealing with crimes against humanity that span the globe.

“The goal is a coherent presentation of all the facts gathered to date, and thus to convince the populations of all countries that resistance here is not only possible, but required of every individual,” Dr. Reiner Fuellmich and Viviane Fischer of the Corona Investigative Committee announced.

Click on the image below to watch the video announcement on Odysee.

Announcement: Start of the Grand Jury Proceeding, 1 February 2022, (5 mins)

Follow the Corona Investigative Committee on Telegram to stay up to date HERE (English).

In an interview with World Council for Health (“WCH”) on 24 January 2022 Dr. Fuellmich explained the trial in more detail:

“We’re going to base it on the American grand jury proceeding. And what we’re going to do is: we’re going to present all the evidence that we have now to the jury. The jury, in this case, being our viewers. And that is only the first step.

“We’re using a real judge, a Portuguese judge [and] we’re [using], of course, real lawyers.  We have real experts, including Mike Yeadon and Ulrike Kämmerer and all the others. And, we have real witnesses who will explain, and tell the people about the damages that they suffer in particular because of the so-called vaccinations of course.

“Ultimately this will hopefully end up with an indictment against the six figure heads, which we picked as future defendants, we know they’re only symbolic, but still: Dresdon, Fauci, Tedros, Gates, BlackRock and Pfizer.

“It is not so much about getting indictments against these people and institutions but rather, what we really have in mind is, to give the people the whole story. Not just pictures of the puzzle, but the whole story through a judicial proceeding, which has credibility and authority to enable them to understand that they not only have a right, but a duty to resist. Because as it will be made very clear, this is about life and death now.”

Click on the image below to watch the video on Rumble.

WCH: Reiner Fuellmich: How a Grand Jury Will Prosecute Covid Crimes, 24 January 2022 (44 mins)

You can read the transcript for WCH’s interview with Dr. Fuellmich HERE.

Further resources:

Official Data shows Children are up to 52 times more likely to die following Covid-19 Vaccination than Unvaccinated

via Daily Expose

The Office for National Statistics has revealed without realising it that children are up to 52 times more likely to die following Covid-19 vaccination than children who have not had the Covid-19 vaccine.

Back on 20th Dec 21, the Office for National Statistics (ONS) published a dataset containing details on ‘deaths by vaccination status in England’ between 1st Jan and 31st Oct 21.

The dataset contains various tables showing details such as, ‘Monthly age-standardised mortality rates by vaccination status for deaths involving COVID-19’, and ‘Monthly age-standardised mortality rates by vaccination status for non-COVID-19 deaths’.

What the dataset also includes is ‘age-standardised mortality rates by age-group and vaccination status for all deaths’, however they have conveniently left out the data for children, and only included data on age groups over the age of 18.

What they also did in the data they included is bunch all young adults together meaning the rates of death are calculated for 18-39 year-olds, a total of 22 years. But for every other age group the rates of death are calculated for a total of 10 years, with 40-49, 50-59 etc.

However, on table 9 of the ‘Deaths by Vaccination Status’ dataset, the ONS have inadvertently provided enough details on deaths among children and teenagers by vaccination status for us to calculate the mortality rates ourselves, and to put it bluntly, they are horrifying, and make it obvious as to why the ONS chose to exclude children from the mortality rates dataset.

What the ONS have done, as can be seen in the above table, is provide an age standardised mortality rate per 100,000 person-years, rather than per 100,000 population.

The reason for this is that the size of each vaccination status population has been changing all the time, due to the unvaccinated moving into the one-dose category, and the one-dose vaccinated moving into the two-dose vaccinated category throughout the year.

So by doing it this way it provides a much more accurate picture of the mortality rates because it accounts both the number of people and the amount of time a person has spent in each vaccination status.

And on table 9, the ONS have provided us with the number of deaths by vaccination status among children and teenagers, and have kindly also provided us with the person-years, meaning we can calculate the mortality rate per 100,000 person years for 10-14 year olds, and 15-19 year olds by vaccination status.

According to the ONS, between 2nd January and 31st October 2021 there were 96 deaths recorded among 10-14-year-olds who had not been vaccinated, and 160 deaths recorded among 15-19-year-olds who had not been vaccinated.

The ONS have calculated the person-years among unvaccinated 10-14 year-olds during this period to be 2,094,711, whilst they’ve calculated person-years among unvaccinated 15-19 year-olds during this period to be 1,587,072.

To work out the mortality-rate per 100,000 person years all we need to now do is divide the person-years by 100,000, and then divide the number of deaths by the answer to that equation.

So for 10-14 year-olds we perform the following calculation –

2,094,711 (person-years) / 100,000 = 20.94711

96 (deaths) / 20.94711 = 4.58

Therefore, the mortality rate per 100,000 person-years among unvaccinated 10-14-year-olds is 4.58 deaths per 100,000 person-years between 1st Jan and 31st Oct 21.

By using the same formula we find that the the mortality rate among unvaccinated 15-19-year-olds is 10.08 deaths per 100,000 person-years.

Now all we have to do is use the same formula to calculate the mortality rate among one-dose vaccinated and two dose vaccinated 10-14, and 15-19 year-olds, by using the person-years and number of deaths provided by the ONS in table 9 of their ‘Deaths by Vaccination Status’ report, which are as follows –

Source Data

Source Data

Here are the calculated mortality rates by vaccination status among 15-19-year-olds based on the ONS calculated person-years –

Source Data

And here are the calculated mortality rates by vaccination status among 10-14-year-olds based on the ONS calculated person-years –

Source Data

These figures are horrifying. The ONS data shows that between 1st Jan and 31st Oct 21, children aged 10-14 were statistically 10 times more likely to die than unvaccinated children, and teenagers aged 15-19 were statistically 2 times more likely to die than unvaccinated teenagers.

But it’s the double vaccinated figures that are truly frightening.

The ONS data shows that between 1st Jan and 31st Oct 21, teenagers aged 15-19 were statistically 3 times more likely to die than unvaccinated teenagers, but children aged 10-14 were statistically 52 times more likely to die than unvaccinated children, recording a death rate of 238.37 per 100,000 person years.

Source Data

But these figures are in fact even worse than they first appear, as if they weren’t already bad enough. This is because the unvaccinated mortality rate among 10-14-year-olds includes children aged 10 and 11 who are not eligible for vaccination.

Whereas the vaccinated mortality rates do not include 10 and 11 year olds because they were not eligible for vaccination at the time, with the JCVI only recently recommending on 22nd Dec 21 that 5 to 11-year-old children deemed to be high risk should be offered a Covid-19 vaccination.

Therefore, if the Covid-19 injections were not causing the untimely deaths of children then we would actually expect to see a mortality rate that is lower among the vaccinated population than the mortality rate among the unvaccinated population, not a mortality rate that is similar, and certainly not a mortality rate 52 times higher.

This jaw dropping and horrifying data should be national headline news, and we dread to think what the numbers will be in the next update from the ONS which will include data on millions of more children who received their 1st and 2nd dose of a Covid-19 vaccine after October 31st 2021.

BOMBSHELL: Incubation Just 2 Days, Half Never Get Infected


Findings from the UK’s world-leading human challenge study provide new insights into mild infections with SARS-CoV-2 in healthy young adults.
The collaborative study is the first in the world to perform detailed monitoring over the full course of COVID-19, from the moment a person first encounters SARS-CoV-2, throughout the infection to the point at which the virus is apparently eliminated.
The Human Challenge Programme is a partnership between Imperial College London, the Vaccine Taskforce and Department of Health and Social Care (DHSC), hVIVO (part of Open Orphan plc.), and the Royal Free London NHS Foundation Trust.
Among several key clinical insights, researchers found that symptoms start to develop very fast, on average about two days after contact with the virus. The infection first appears in the throat; infectious virus peaks about five days into infection and, at that stage, is significantly more abundant in the nose than the throat.
They also found that lateral flow tests (LFTs) are a reassuringly reliable indicator of whether infectious virus is present (i.e., whether they are a likely to be able to transmit virus to other people).
The findings, published on a pre-print server and which have not yet been peer-reviewed, detail the outcomes in 36 healthy, young participants with no immunity to the virus.
This landmark study, which took place at a specialist unit at the Royal Free Hospital in London, shows that experimental infection of volunteers is reproducible and resulted in no severe symptoms in healthy young adult participants, laying the groundwork for future studies to test new vaccines and medicines against COVID-19.
Professor Christopher Chiu, from the Department of Infectious Disease and the Institute of Infection at Imperial College London and Chief Investigator on the trial, said: “First and foremost, there were no severe symptoms or clinical concerns in our challenge infection model of healthy young adult participants.
“People in this age group are believed to be major drivers of the pandemic and these studies, which are representative of mild infection, allow detailed investigation of the factors responsible for infection and pandemic spread.
“Our study reveals some very interesting clinical insights, particularly around the short incubation period of the virus, extremely high viral shedding from the nose, as well as the utility of lateral flow tests, with potential implications for public health.”

Clinical insights

In the trial, 36 healthy male and female volunteers aged 18-30 years, unvaccinated against COVID-19 and with no prior infection with SARS-CoV-2 were given a low dose of the virus – introduced via drops up the nose – and then carefully monitored by clinical staff in a controlled environment over a two-week period. The study used virus from very early in the pandemic obtained from a hospitalized patient in the ISARIC4C study, prior to the emergence of the Alpha variant.
Eighteen of the volunteers became infected, 16 of whom went on to develop mild-to-moderate cold-like symptoms, including a stuffy or runny nose, sneezing, and a sore throat. Some experienced headaches, muscle/joint aches, tiredness and fever.
None developed serious symptoms. Two participants were excluded from the final analysis after developing antibodies between initial screening and inoculation.
Thirteen infected volunteers reported temporarily losing their sense of smell (anosmia), but this returned to normal within 90 days in all but three participants – the remainder continue to show improvement after three months.
There were no changes seen in their lungs, or any serious adverse events in any participant. All participants will be followed up for 12 months after leaving the clinical facility to monitor for any potential long-term effects.
Participants were exposed to the lowest possible dose of virus found to cause infection, roughly equivalent to the amount found in a single droplet of nasal fluid when participants were at their most infectious.

Accurate timeline of infection

The study has also revealed some unique insights into the timeline of COVID-19, particularly during the very early period after virus exposure that cannot be looked at in other types of study, where patients are not identified until symptoms are noticed.
Among the 18 infected participants, the average time from first exposure to the virus to viral detection and early symptoms (incubation period) was 42 hours, significantly shorter than existing estimates, which put the average incubation period at 5-6 days.
Following this period there was a steep rise in the amount of virus (viral load) found in swabs taken from participants’ nose or throat.
These levels peaked at around five days into infection on average, but high levels of viable (infectious) virus were still picked up in lab tests up to nine days after inoculation on average, and up to a maximum of 12 days for some, supporting the isolation periods advocated in most guidelines.
There were also differences in where the most virus was found. While the virus was detected first in the throat, significantly earlier than in the nose (40 hours in the throat compared to 58 hours in the nose), levels were lower and peaked sooner in the throat.
Peak levels of virus were significantly higher in the nose than in the throat, indicating a potentially greater risk of virus being shed from the nose than the mouth. This highlights the importance of proper facemask use to cover both the mouth and nose.

Lateral flow tests

Importantly, lateral flow tests (LFTs) were shown to be a good indicator of whether someone was harbouring viable virus. Positive LFTs correlated well with lab-confirmed detection of virus from swabs throughout the course of infection, including in those who were asymptomatic. However, the tests were less effective in picking up lower levels of virus at the very start and end of infection.
This is the first study that has been able to provide detailed data on the early phase of infection, before and during the appearance of symptoms. While there is a possibility of missing infectious virus early in the course of infection, particularly if only the nose is tested, the researchers say these findings overall support continued use of LFTs to identify people likely to be infectious.
The study provides supportive evidence that LFTs can reliably predict when someone is unlikely to infect others and can come out of isolation, and that twice-weekly rapid tests would allow diagnosis before 70-80% of viable virus was generated during the course of infection.
“We found that overall, lateral flow tests correlate very well with the presence of infectious virus,” said Professor Chiu. “Even though in the first day or two they may be less sensitive, if you use them correctly and repeatedly, and act on them if they read positive, this will have a major impact on interrupting viral spread.”
The authors highlight that while the model is a safe and effective approximation of real-world infection in young adults, the small sample size, reduced diversity of infected volunteers and limited follow up period may restrict the findings.
However, they add that despite these limitations, the study has important implications for public health, including around proper mask-wearing, isolation periods for infectious individuals, the use of LFTs, and establishing the human challenge platform to investigate further aspects of COVID-19.
Future work will see the team determine why some people became infected and others did not and develop a challenge virus using the Delta variant, which is already underway by Imperial in partnership with hVIVO and funded by the Wellcome Trust, and which could be used in follow-on trials.
According to the team, with these data supporting the safety of the infection challenge model and a Delta variant available, this could theoretically provide a ‘plug and play’ platform for testing new variants and therapies, including vaccines.
Professor Chiu added: “While there are differences in transmissibility due to the emergence of variants, such as Delta and Omicron, fundamentally, this is the same disease and the same factors will be responsible for protection against it.
“From the point of view of virus transmission related to the very high viral loads, we are likely if anything to be underestimating infectivity because we were using an older strain of the virus. With a newer strain, there might be differences in terms of size of response, but ultimately we expect our study to be fundamentally representative of this kind of infection.”
Professor Sir Jonathan Van-Tam, Deputy Chief Medical Officer for England, said: “Human challenge studies have been performed using other pathogens for decades, including flu and Respiratory Syncytial Virus (RSV). They need full independent ethical review and very careful planning – as has been the case this time. Every precaution is taken to minimise risk. “Scientifically these studies offer real advantage because the timing of exposure to the virus is always known exactly, therefore things like the interval between exposure and the profile of virus shedding can be accurately described. “This important study has provided further key data on COVID-19 and how it spreads, which is invaluable in learning more about this novel virus, so we can fine-tune our response. Challenge studies could still prove to be important in the future to speed the development of ‘next-generation’ Covid-19 vaccines and antiviral drugs. “These data underline just how useful a tool lateral flow tests can be to pick up people when infectious and the importance of wearing a face covering in crowded, enclosed spaces.”
 

Coronavirus Circulated in Italy From September 2019, WEF Reported

Coronavirusi italy covid italian milan lombardy europe european detected study date early month feburary september virus health healthcare who world health organization disease deaths pandemic epidemic worries concerns Health virus contagious contagion viruses diseases disease lab laboratory doctor health dr nurse medical medicine drugs vaccines vaccinations inoculations technology testing test medicinal biotechnology biotech biology chemistry physics microscope research influenza flu cold common cold bug risk symptomes respiratory china iran italy europe asia america south america north washing hands wash hands coughs sneezes spread spreading precaution precautions health warning covid 19 cov SARS 2019ncov wuhan sarscow wuhanpneumonia pneumonia outbreak patients unhealthy fatality mortality elderly old elder age serious death deathly deadly
Italy was first European country to have a major outbreak of COVID-19.
Image: REUTERS/Guglielmo Mangiapane

via World Economic Forum

  • COVID-19 was circulating in Italy from September 2019, according to a study by the Italian National Cancer Institute.
  • Italy’s first official COVID-19 case was detected on February 21st.
  • The new study which re-examined samples from a lung cancer screening trial between September 2019 and March 2020, suggests otherwise.
  • It showed that of the 959 healthy volunteers enrolled in the trial, 11% had developed coronavirus antibodies well before February.
  • A study by the University of Siena also supports this theory.

The new coronavirus was circulating in Italy since September 2019, a study by the National Cancer Institute (INT) of the Italian city of Milan shows, signaling that COVID-19 might have spread beyond China earlier than previously thought.

The World Health Organization has said the new coronavirus and COVID-19, the respiratory disease it causes, were unknown before the outbreak was first reported in Wuhan, in central China, in December.

Italy’s first COVID-19 patient was detected on Feb. 21 in a little town near Milan, in the northern region of Lombardy.

But the Italian researchers’ findings, published by the INT’s scientific magazine Tumori Journal, show that 11,6% of 959 healthy volunteers enrolled in a lung cancer screening trial between September 2019 and March 2020, had developed coronavirus antibodies well before February.

A further specific SARS-CoV-2 antibodies test was carried out by the University of Siena for the same research titled “Unexpected detection of SARS-CoV-2 antibodies in the pre-pandemic period in Italy”.

It showed that four cases dated back to the first week of October were also positive for antibodies neutralizing the virus, meaning they had got infected in September, Giovanni Apolone, a co-author of the study, told Reuters.

“This is the main finding: people with no symptoms not only were positive after the serological tests but had also antibodies able to kill the virus,” Apolone said.

“It means that the new coronavirus can circulate among the population for long and with a low rate of lethality not because it is disappearing but only to surge again,” he added.

Italian researchers told Reuters in March that they reported a higher than usual number of cases of severe pneumonia and flu in Lombardy in the last quarter of 2019 in a sign that the new coronavirus might have circulated earlier than previously thought.

Reporting by Giselda Vagnoni; editing by Emelia Sithole-Matarise

Sweden Lifts Nearly All Covid-19 Restrictions

In a press conference on Thursday morning, the Swedish government announced plans to remove the majority of restrictions against Covid-19 on February 9th, the Local.se reported.

Prime Minister Magdalena Andersson, Health Minister Lena Hallengren and the Director General of the Public Health Agency, Karin Tegmark Wisell, announced that almost all restrictions will be removed on February 9th, and that those working from home should prepare to return to work.

Health Minister Lena Hallengren, Prime Minister Magdalena Andersson and Director General of the Public Health Agency Karin Tegmark Wisell at Thursday’s press conference. Photo: Marko Säävälä/TT

“The pandemic is not over, but is entering a completely new phase,” said Andersson. “We are nearing the point for Sweden to open up again.”

The government explained that the decision to open up was based on a number of factors, partly that Omicron appears to be a milder variant of the virus, and partly that the percentage of Sweden’s population who are fully vaccinated or have taken a booster dose continues to increase.

“There are multiple international studies of a milder illness, and the data we have from Sweden paints the same picture,” Andersson explained. “The rate of vaccination in Sweden has been high in recent weeks,” she continued, stating that this means that “we can open up society, at least for all who have been vaccinated”.

Almost 50 percent of over-18s in Sweden have received their third dose of the vaccine, and more than 86 percent of over-12s have received their first dose. Sweden does not recommend the Covid vaccines to children under the age of 12, unless they are particularly at risk.

Health Minister Lena Hallengren also stated that “the government is planning on removing travel restrictions introduced on December 21st for the Nordic countries”, stating that they would provide more information as soon as it was possible.

She didn’t say anything about travel restrictions for other countries. Sweden’s current entry rules for EU/EEA arrivals are currently in place until February 28th, and March 31st for people travelling from other countries.

In terms of returning to work and higher education, Hallengren stated that “in order to prevent a new wave, the return to work and school should occur successively”.

Which restrictions will be removed?

The following restrictions will be removed next week:

  • Indoor events of 20-50 people must be seated, with max 8 per group and one metre between groups
  • Vaccination pass needed for indoor events with more than 50 attendees
  • Trade shows and markets indoors must require a vaccine pass if they have more than 50 guests, and number of guests is capped at 500, with 10 square metres per person
  • Restaurants must close at 11pm, with alcohol serving ending at 10.30pm
  • Groups at restaurants may consist of a maximum of eight people, with a minimum of one metre between groups
  • Restaurants with conserts or other entertainment may only have seated guests
  • Maximum of 20 people at private parties in hired venues
  • Shops must have a maximum number of guests permitted, calculated on area with 10 square metres per person – this also applies to gyms, museums, art galleries, theme parks and swimming pools
  • Long-distance public transport: all travellers must have a seat, if possible

In addition to this, special recommendations for those who have not yet been vaccinated will remain, as well as recommendations to stay home when sick, or if you suspect you may have Covid-19.

Covid-19 ‘no longer a danger to society’

The Public Health Agency also believes that Covid-19 should no longer be classified as an illness presenting a danger to society. Therefore, the agency has sent a request to the government in order to reclassify the illness.

“The government will process this request in a swift manner and will also put forward a law proposal to reclassify Covid-19,” Hallengren said, indicating that this could happen by the end of March. After the government has submitted these proposals, parliament will make the final decision on whether to approve them or not.

Sweden confirmed its highest number of daily new cases of Covid-19 last week, the highest level yet during the pandemic. There was also a clear rise in the number of Covid-linked deaths and intensive care admissions last month, albeit not as much as during previous waves.

With over 16,000 fatalities so far, Sweden’s death toll is in line with the European average, but is far higher than those of neighbouring Norway, Finland and Denmark.

Denmark on Tuesday became the first European Union country to lift most of its domestic Covid-19 restrictions, followed later in the day by Norway.

via ZeroHedge

AI says Israel is an “Apartheid State” – Silence.

by Tom Fowdy

Earlier this week, Amnesty International released a report branding Israel an “apartheid state” and accusing it of a “crime against humanity” in its treatment of Palestinians. Despite the gravity of these findings, and the report’s wide circulation on social media, the political and media response to it was, predictably, muted.

Indeed, Australian Prime Minister Scott Morrison dismissed the report, merely remarking that “no country is perfect,” while the US State Department openly attacked it in their daily press briefing.

The BBC, which has run regular coverage of human rights issues in China, and makes a point in astroturfing any report Amnesty publishes on Beijing – including publishing one article branding the Xinjiang region a “dystopian hellscape” – also conveniently omitted the Israel news from the front page of its website. It was criticised by some on social media for not featuring it on its flagship TV news programme (instead including a piece on the puzzle, Wordle).

In a nutshell, a country was accused of crimes against humanity in an extensive report, and the US and its allies simply ignored it. The same people making a lot of noise over the Chinese region of Xinjiang were somehow unavailable for comment.

Without wishing to address the specific merits of what Amnesty is claiming regarding Israel, there is a wider issue worth looking at here. And that is understanding how the comparative reactions to Israel- and China-related issues mark a firm demonstration of the way that the rhetoric of human rights is opportunistically and manipulatively weaponized in Western political and media discourse as a means to advance foreign policy objectives.

Quite simply, there is a noticeable and deliberate inconsistency in the level of attention and urgency given to certain issues, which shows how human rights are used as a stick to shape public opinion as opposed to being a genuine concern.

This is part of a process known as ‘manufacturing consent’, whereby atrocity-based propaganda is used to build emotional and political opposition to target countries for geopolitical reasons, but is never utilised sincerely and consistently. The reactions to Amnesty’s Israel report, relative to China’s treatment over Xinjiang, serve as an important case study in demonstrating this insincerity.

Western liberal ideology is able to manipulate so readily through the assumptions it peddles to its own populations concerning its own identity. In the West, nations consider themselves to possess an ultimate state of political enlightenment and that their values constitute an absolute political and moral truth. Within this context, these values and ‘liberal democracy’ can never be used in a bad faith, insincere, or opportunistic way.

This thinking is derived from the legacy of Christianity, where one side has the truth, and acts with pure intent, and the other does not. This shapes the Western view of the world as a binary clash between good and evil, and instils the belief that the West has a divine right to project its values onto others.

This viewpoint, however, negates the reality that people are at heart motivated by self-interest, and that it is characteristic of human social behaviour to use value sentiments to advance their own interests.

Human rights are undeniably important. However, it is wrong to assume that they exist on a higher plane than the material world we live in, and that all moralistic rhetoric is holistically distinct from people’s financial and political interests.

While Western politicians understand this, Western populations, generally, do not, which means many genuinely believe their governments espouse the rhetoric of human rights in a moralistic, benevolent mission to save other people.

It is for this reason that World War I and World War II have been popularly understood not as hegemonic struggles between conflicting empires, but righteous battles between good and evil fought purely out of altruism and for the sake of freedom. This explains why human rights are often used deceptively and selectively to drive an agenda.

The public see the relentless focus by the Western media on issues such as Xinjiang – with certain ‘experts’ regularly presented to provide commentary – and do not recognise that it is a deliberate manipulation campaign to incite hatred against China. Instead, they believe that it is an objective set of facts being presented to them by concerned, impartial media on an issue of moral alarm and importance, and there is no agenda but to help the people involved. In other words, the public are made to care about issues that the media want them to care about.

This is why Xinjiang has been relentlessly focused on by the Western media, with references to ‘genocide’ and ‘crimes against humanity’, but similar accusations are not consistently applied in coverage elsewhere, because it is deliberatively selective. When the BBC, for one, runs a story concerning Israel, do you ever see a line to the effect of ‘Israel is accused of committing crimes against humanity’ or ‘there are concerns about human rights abuses in Israel’?

This moralistic sense of self-superiority and the selective discourse of ‘concern’ make it very difficult for one to argue against the narrative being presented, because in the Western mindset, what is deemed to be morally true is also considered to be empirically true. While the West is assumed to always act in good faith in making such accusations, the opposite is true of those who counter them. They are accused of acting in bad faith.

The West can opportunistically push a human rights issue to build support for a war, sanctions, or something else, and anyone who challenges this is deprived of their own agency. Hence, there can be no legitimate objections to coverage of Xinjiang, because anyone who flags inconsistencies or concerns ‘must be paid by the Communist Party of China’ or be a ‘state actor’. Hence the weaponization of human rights becomes an irrefutable dogma in which questioning the motivations behind it places you on par with those committing the crime itself.

The reactions to the latest Amnesty report have served as an important example in showing how human rights have become a political weapon. If you are an activist against China, such as the NBA’s Enes Kanter Freedom, you will be given a platform by Western mainstream media and maximum publicity. While he no doubt sincerely believes in his own cause, he is being weaponized as a tool of public manipulation. As another example, consider how Donald Trump, during the campaign of ‘maximum pressure’ against North Korea, began using defectors, as well as the parents of Otto Warmbier – who died after being held in captivity in the county – in his publicity campaign. But the moment his policy changed and he decided to negotiate with Kim Jong-un, these people disappeared and we have rarely heard from them since.

But if you are an activist against Israel, or are campaigning against reported Indian human rights abuses in Jammu and Kashmir, or are opposing the brutal war in Yemen, you will probably find that the Western mainstream media ignores you.

It’s abundantly clear that it doesn’t matter how grave the crimes you are warning the world about are, what really matters is the politics. The highlighting of abuses in one part of the world that are ignored elsewhere should set the alarm bells ringing for any critical thinker.

More Confirmation: The Hoax is Being Canceled

Europe can hope for a “long period of tranquility,” Dr. Hans Kluge says

During a virtual press briefing conducted by the World Health Organization (WHO) on Thursday, Dr. Hans Kluge, regional director for Europe, announced that the continent could be entering a “long period of tranquility” and security in the global Covid-19 pandemic.

Talking to the reporters, he said Europe had the “unique opportunity to take control of transmission” due to three factors: high vaccination and natural immunity rates among European citizens, favorable seasonal conditions as winter approaches its end, and the lower severity of the Omicron variant.

“This period of higher protection should be seen as a ‘ceasefire’ that could bring us enduring peace,” he said in the video.

Despite the fact that Covid-19 cases have reached their highest since the start of the pandemic due to the more contagious nature of the Omicron variant, Covid death rates and intensive care admissions are starting to stabilize, according to Dr. Kluge.

He urged the European authorities to continue their vaccination policies, focus on protecting the most vulnerable groups, promote self-defensive behavior, and increase surveillance to detect new variants of Covid-19.

“I believe that it is possible to respond to new variants that will inevitably emerge without reinstalling the kind of disruptive measures we needed before,” he noted.

The regional director also addressed the necessity of increasing “vaccine sharing across borders” in order to fight the pandemic worldwide.

The WHO virtual press conference was conducted amid multiple European nations deciding to end or significantly soften their Covid-19 restrictions. Denmark, Ireland, Norway, France, and Sweden have already decided to relax restrictive measures in the coming weeks, with Finland, Italy and Switzerland expecting to conduct government discussions on the matter in the coming days.

According to WHO statistics, Europe has seen more than 11,800,000 Covid-19 cases and more than 22,000 deaths in the last seven days.

Here’s Why Soros’ Attack on China is Illogical and Ignorant

by Bradley Blankenship via RT

Billionaire George Soros, the founder of the Open Society Foundations, gave a speech this week to the conservative Hoover Institution in which he compared China under President Xi Jinping to Nazi Germany and called for regime change in Beijing.

Soros said in his speech, “Xi Jinping has done his best to dismantle Deng Xiaoping’s achievements. He brought private companies under Deng under the control of the [CPC] and undermined the dynamism that used to characterize them.” He also said that Xi, unlike other Chinese leaders like Deng Xiaoping, is “a true believer in communism,” and added: “It is to be hoped that Xi Jinping may be replaced by someone less repressive at home and more peaceful abroad.”

Apart from the facts that this is a pretty bold attempt to interfere in China’s internal affairs and that it ignores the reality that Beijing’s government has a trust rating of 91% from its citizens, Soros’ assessment of what’s going on in the country is extraordinarily ignorant and, for the most part, just not true.

For starters, Xi is not undoing anything that Deng did with regards to China’s opening up and reform policies. In fact, Xi has only doubled down on such policies and every single one of Xi’s remarks on the subject emphasizes leaning into globalization and removing barriers to international trade. (See: Xi’s latest WEF speech).

For example, just this year the largest free-trade zone in the world, the Regional Comprehensive Economic Partnership (RECP), a Chinese-led initiative in the Asia-Pacific region, was established. This zone encompasses some 30% of both the world’s population and GDP. Does that really sound like a society that is closing itself off?

The numbers also paint a clear picture. China’s General Administration of Customs (GAC) announced on January 14 that the country’s trade volume exceeded six trillion dollars for the first time in 2021. On top of this, foreign investment into the Chinese mainland expanded 14.9% year-on-year to a record high of 1.15 trillion yuan in 2021. In dollar terms, this increase was a 20.2% year-on-year increase to a total of 173.48 billion dollars.

Second, China’s dynamism is only increasing in the Xi era. By one crucial metric, the UN’s intellectual property agency has posted China as having the highest number of patents filed in the world since 2020.

Chinese telecom giants like Huawei and ZTE are lightyears ahead of their Western counterparts, and so much so that some US client states have to manufacture ‘national security threats’ to bar Chinese companies from public tenders. China’s State-owned China National Nuclear Corp (CNNC) just inked a deal with Argentina on Tuesday to build a reactor using China’s Hualong One technology, which is only the second time ever China has exported its nuclear technology and the first time it’s won a highly competitive contract.

In addition, China is already an unsung industry leader in e-commerce. Boasting the largest e-commerce sector in the world, larger than the US and EU combined, Chinese consumer spending is projected by Morgan Stanley to double to about $12.7 trillion by 2030. This would essentially put China’s consumer spending at current US consumer spending.

As the ongoing Covid-19 pandemic pushes more and more shopping online in the West, major companies like Meta, Walmart, and Amazon are simply lifting features from Chinese e-commerce that existed pre-pandemic to boost an increasingly online market. To quote a popular saying, “If you want to know what Amazon will do in two or three years, just look at what China’s doing now.”

Finally, to state the obvious, Deng Xiaoping was a committed communist. There’s no doubt about it. China’s reform and opening-up policies were not a backstep toward capitalism, rather they were instituted to address the stagnation that gripped the world at that time. The CPC made a strategic decision to open up to the Western world to develop its productive forces, namely new technologies and new skills to infuse into the labor force.

“In China, we intend to acquire advanced technology, science and management skills to serve our socialist production. And these things as such have no class character,” Deng was quoted as saying in 1984.

I believe that this final point is the root of many Westerners’ misperception of China, including what we see here from Soros. They believed at the time of China’s reform and opening-up that inflows of capital would essentially create a miniaturized version of capitalism with China, leading to the ending of Communist Party rule and ushering in a Western-style government.

However, no one in the CPC, including Deng, believed this would happen, or wanted it. To quote Deng again, when asked about this exact same scenario in 1980 by an Italian journalist:

“No matter to what degree China opens up to the outside world and admits foreign capital, its relative magnitude will be small and it can’t affect our system of socialist public ownership of the means of production.”

He continued, “Absorbing foreign capital and technology and even allowing foreigners to construct plants in China can only play a complementary role to our effort to develop the productive forces in a socialist society. Of course, this will bring some decadent capitalist influences into China. We are aware of this possibility; it’s nothing to be afraid of.”

Indeed, Deng’s prescriptions did come into play – and Xi, in my opinion, simply followed the same line. For example, when we read this quote about “some decadent capitalist influences” in China and how the CPC was not afraid of it, probably because they knew how to address it, this seems to be the entire basis for Xi’s sweeping anti-corruption campaign that also uprooted a CIA informant network.

I think the assumption that China’s reform and opening-up would naturally lead to regime change was stupid from the start and people like Soros are just salty that their spies got caught. They’re mad that China is no longer a sidecar to Western countries and is becoming a dominant geopolitical player in its own right.

Iowa Lawmakers to Allow Ivermectin Use For Critically Sick Patients:

Authored by Jack Phillips via The Epoch Times,

Lawmakers in Iowa’s state Legislature have advanced a bill that would allow the use of ivermectin for critically sick COVID-19 patients.

Ivermectin has been used for decades to treat parasitic worms in humans, but during the COVID-19 pandemic, some patients and doctors have attested that the drug is effective in relieving symptoms.

The Iowa bill stipulates that COVID-19 patients who are on ventilators should have the ability to use ivermectin. Specifically, it expands the state’s “right to try” law, which allows terminally ill patients to access medicines that have passed under the first phase of the U.S. Food and Drug Administration’s trials.

“I completely support it. I think that we should give patients the right to try,” said Rep. Ann Meyer, a Republican and one of the bill’s cosponsors, told the Des Moines Register in late January.

Rep. Lee Hein, also a Republican, said he sponsored the measure after hearing that two families of critically ill COVID-19 patients had sought ivermectin but hospital policies prevented them from obtaining the medication. Both patients died of COVID-19, he said.

“I don’t know whether any of these drugs work, but I think at that late stage in the game, once you’re on a ventilator, families ought to have at least a glimmer of hope to try something,” Hein told Radio Iowa.

The FDA’s website says that its “currently available data” suggests that the medication isn’t effective at treating or preventing COVID-19. However, the agency courted controversy last year when it issued a Twitter post that suggested the drug is only used for “deworming” horses and other livestock, although it has long authorized ivermectin tablets as a treatment for worms in humans.

The FDA and other agencies, meanwhile, have warned against people taking livestock-grade ivermectin, which doesn’t require a prescription, amid reports of increases in people being admitted to hospitals after taking the livestock version of the drug.

The drug gained more attention after podcaster Joe Rogan confirmed that he took human-grade ivermectin in a bid to curb his COVID-19 symptoms. Ivermectin is also being used across Latin America for COVID-19, including in Peru, Guatemala, Bolivia, and other countries.

In December of last year, the family of an Illinois man, Sun Ng, who developed severe COVID-19 symptoms and was near death, said he recovered after taking ivermectin. It came after a court ordered the hospital to administer the drug to Ng, the family’s attorney told The Epoch Times at the time.

Rep. Meyer, who is a also nurse, said that ivermectin has “been around” for “many years.” The bill, she told Radio Iowa, would allow “off-label” use of the drug for COVID-19 patients who are on life support in hospitals.

Republicans advanced the measure through a subcommittee meeting on Jan. 26.

One Democrat on the subcommittee, Rep. Mary Mascher, voted against advancing the bill.

“There’s a lot of folks in the room who are medical folks,” Mascher said during last week’s hearing. “And I have heard no one in support of the bill.”